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ABSTRACT
Four unsaturated polyketide lactone derivatives, coibacins AD, were isolated from a Panamanian marine cyanobacterium, cf. Oscillatoria sp.
The two different types of termini observed in these co-occurring metabolites, either a methyl cyclopropyl ring as seen in curacin A or a methyl
vinyl chloride similar to that observed in the jamaicamides, suggest an intriguing flexibility in the “beta branch” forming biosynthetic process.
The coibacins possess selective antileishmanial activity as well as potent anti-inflammatory activity.
The secondary metabolites of filamentous marine cya-
nobacteria show a surprising degree of structural diversity
and biological activity.1 For example, a methyl cyclopro-
pyl ring is found in the curacin series of anticancer meta-
bolites isolated fromMoorea producens (formerlyLyngbya
majuscula2) (Figure 1, compound 5),3 whereas vinyl chlo-
ride moieties are present in the jamaicamides (e.g. 6),
isolated from a Jamaican collection of M. producens,4 as
well as in most of the more than two dozen malyngamide
natural products.5 Study of the biosyntheticmechanism of
formation of these two moieties revealed they are variant
products of closely related manifolds, differing only in the†University of California San Diego.
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site of proton delivery following enoyl CoA hydratase
mediated decarboxylation and, subsequently, enoyl reduc-
tase catalyzed hydride addition in the case of curacin A to
form the cyclopropyl ring.6 Previously, these two distinc-
tive structural features have never been reported from a
single organism, and their co-occurrence here suggests an
intriguing flexibility in the biosynthetic manifold.
Prefractionation of the CH2Cl2/MeOH extract of a cf.
Oscillatoria species collected in theCoibaNational Park as
part of thePanama InternationalCooperativeBiodiversity
Group (ICBG) resulted in several fractions with potent
activity to axenic amastigotes of Leishmania donovani.7
Purification using RP-SPE followed by RP HPLC (C18)
gave coibacins AD (14) as the active compounds
(Figure 1). 1H NMR analysis indicated that all four com-
pounds containedanR,β-unsaturatedδ-lactone.However,
metabolites 1 and 2 exhibited signals typical of a methyl-
substituted cyclopropyl ring, whereas compounds 3 and 4
showed signals diagnostic for methyl vinyl chloride moi-
eties (Table 1).
High-resolution mass measurement of the sodiated mo-
lecular ion for coibacin A (obsdm/z [M þNa]þ 307.1670,
calcd m/z 307.1669) yielded a molecular formula of
C19H24O2 with 8 degrees of unsaturation. By COSY and
HMBC, 1 was determined to possess two conjugated
dienes separated by two methylene groups, and by cou-
pling constant analysis (all J values >12 Hz), the double
bonds were entirely trans (Table 1). At one end, this linear
chain was linked to the unsaturated lactone ring and at the
other to the methyl cyclopropyl ring, thus completing the
planar structure. The absolute configuration of the R,
β-unsaturated lactone ring was determined using circular
dichroism. The CD of 1 exhibited a positive Cotton effect
atλ259nm,whichmatcheswellwith theS configurationof
model R,β-unsaturated lactone rings.8 However, because
coibacin A has other UV chromophores adjacent to chiral
centers, and these could potentially contribute to the CD,
we also meaured the CD of compound 4 (see below) as it
lacks any chromophore other than the unsaturated lac-
tone. The CD curves of 1 and 4 were nearly superimpo-
sible, thus substantiating our assignment of the con-
figuration of C-5.
The relative configuration of the methyl-substituted
cyclopropyl ring of 1 was determined using NOESY
correlations and J coupling constant analysis (Table 1).
Correlations were observed between the adjacent vinyl
proton (H-15, δ 5.15), one of the diastereotopic H2-17’s
(δ 0.55), and methine H-18 (δ 0.76). Additional correla-
tions were found betweenmethine H-16 (δ 1.07), the other
H-17 (δ 0.49), and H3-19 (δ 1.05). Taken together with the
coupling constants between these protons (Table 1), these
data indicated that coibacin A (1) possessed a trans-
configured methyl cyclopropyl ring (S*,S*). Unfortu-
nately, because of the low yield of natural product, the
absolute configurations at C-16 and C-18 were not
assigned.
The unsaturated chain of coibacin B (2) was found to be
two carbons shorter than in 1 by HRMS and NMR
analysis. This deletion was localized to one less olefin in
the diene motif adjacent to the methyl cyclopropyl ring. In
all other respects, including optical rotation, the spectro-
scopic data for 2 were essentially identical to those re-
corded for coibacin A (1).
While coibacins C (3) and D (4) had spectroscopic
features similar to coibacins A and B, they were clearly
of a different structural series due to their molecular
formulas, which both contained one chlorine atom. Coi-
bacin C (3), of molecular formula C15H19ClO2 (m/z [M þ
Na]þ 289.0968), possessed the same R,β-unsaturated-
δ-lactone as 1 and 2, but oxymethineH-5was approximately
0.5 ppm upfield and by COSY was located adjacent to a
methylene rather than an olefin. COSY correlations se-
quentially extended this spin system to a secondmethylene
(H2-7), a conjugated diene (E,E by J values, see Table 1),
and a bis-allylic methylene (δ 2.79, H2-12). HMBC corre-
lations connected the latter doublet to quaternary C-13,
methyl C-14, and olefinic C-15 of an adjacent terminal
olefin with β-chloro and R-methyl substituents. Compar-
ison of the 1H and 13C NMR shifts for 3 and for model
Figure 1. Structures of coibacins AD (14) with two other
marine cyanobacterial metabolites of related biosynthetic ori-
gin, curacin A (5) and jamaicamide A (6).
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compounds from the jamaicamide and malyngamide fa-
milies of metabolites confirmed the identity of this
moiety,4,5 and NOE (H-15 to H2-12) was used to define
the E-geometry of this trisubstituted olefin.
CoibacinD (4) was of twomass units greater than 3 (m/z
[MþNa]þ 291.1124) and consistentwith thiswas found to
lack one of the two olefins forming the conjugated diene in
3; by COSY this saturation was localized to the C-8/C-9
position.The geometry of theΔ10 olefinwas trans basedon
a 15.1Hz vicinal J value, and theΔ13 olefinwas assigned as
E given very similar 1H and 13C NMR chemical shifts to
those of coibacin C (3). Coibacins C and D had optical
rotations similar to that of coibacinsA andB, and as noted
above, coibacin D (4) had a CD absorption curve consis-
tent with the S-configuration of an R,β-unsaturated-
δ-lactone (see the Supporting Information).
Purified coibacins AD (14) were tested for activity in
the Panama ICBG suite of tropical disease assays (Figure
S36, Supporting Information). Coibacin A (1) presented
potent activity against Leishmania donovani axenic amas-
tigotes with an IC50 value of 2.4 μM, while the other
coibacins exhibited slightly less activity in this assay
(Table 2). The antileishmanial activity of the coibacins
was confirmed using L. mexicana axenic amastigotes
(Figure S37, Supporting Information); however, when a
L. mexicana macrophage assay was used they were inac-
tive, perhaps indicating a failure to cross the cellmembrane
of these latter cell types.
The coibacins were also tested for activity against ma-
laria and Chagas’ disease and were inactive (IC50 values
>25 μM). In testing against NCI-H460 human lung
cancer cells, coibacin D (4) was the most cytotoxic,
whereas coibacinA (1) was least cytotoxic (Table 2). From
these data, tentative therapeutic indices against Leishma-
nia parasites for 14 were calculated to be 13.1, 2.4, 1.1,
and 1.5, respectively; thus, coibacin A possesses the great-
est selectivity and may be a lead for development of an
antileishmanial drug candidate.
The coibacins were also tested for anti-inflammatory
activity in a cell-based nitric oxide (NO) inhibition assay.9
In this assay, coibacinB (2), was determined to be themost
active (Table 2); however, because coibacin A was more
abundant, it was further evaluated in gene transcription
(TNF-R, IL-6, IL-1b, and iNOS) and protein expression
Table 1. NMR Data for Coibacins AD (14) in CDCl3
coibacin A (1) coibacin B (2) coibacin C (3) coibacin D (4)
no. δC,
a mult δH,
b mult, J (Hz) δC,
a mult δH
b,mult., J (Hz) δC,
a mult δH,
b mult, J (Hz) δC,
a mult δH,
b mult, J (Hz)
1 164.0 (C) 164.0 (C) 164.2 (C) 164.5 (C)
2 121.7 (CH) 6.05,cm 121.7 (CH) 6.05,cm 121.5 (CH) 6.03,m 121.5 (CH) 6.02, dt, 1.9, 9.7
3 144.5 (CH) 6.88, dt, 4.4, 9.8 144.5 (CH) 6.88, dt, 4.9, 9.8 144.8 (CH) 6.88, dt, 4.9, 9.7 144.9 (CH) 6.88, ddd, 3.6, 5.1, 9.8
4 29.8 (CH2) 2.45,m 29.8 (CH2) 2.45,m 29.4 (CH2) 2.35,m 29.4 (CH2) 2.33,m
5 77.9 (CH) 4.94, dt, 7.6, 7.8 77.9 (CH) 4.95,m 77.9 (CH) 4.43,m 77.9 (CH) 4.42,m
6 126.7 (CH) 5.64, dd, 6.7, 15.5 126.6 (CH) 5.64, dd, 6.7, 15.3 34.4 (CH2) 1.73,m 34.7 (CH2) 1.64,m
1.92,m 1.79,m
7 133.7 (CH) 6.30, dd, 10.7, 15.7 133.8 (CH) 6.31, dd, 10.5, 15.4 27.8 (CH2) 1.25,
cm 24.3 (CH2) 1.39,m
1.51,m
8 129.1 (CH) 6.05,cm 129.0 (CH) 6.05,cm 131.0 (CH) 6.05, m 29.1 (CH2) 1.39,m
9 136.8 (CH) 5.77, dt, 6.6, 15.2 137.1 (CH) 5.78, dt, 6.6, 15.3 131.6 (CH) 5.57,m 32.2 (CH2) 2.03, dt, 6.7, 7.0
10 32.6 (CH2) 2.16,m 32.8 (CH2) 2.15,m 128.5 (CH) 5.51,m 126.6 (CH) 5.47, dt, 7.3, 15.1
11 32.1 (CH2) 2.16,m 32.0 (CH2) 2.07,m 132.3 (CH) 6.05,m 132.8 (CH) 5.34, dt, 6.9, 15.2
12 129.9 (CH) 5.50, dt, 7.3, 14.5 126.4 (CH) 5.43, dt, 6.9, 15.3 40.1 (CH2) 2.79, d, 7.1 40.2 (CH2) 2.72, d, 6.8
13 130.8 (CH) 5.97,m 134.3 (CH) 5.00,m 137.4 (C) 137.9 (C)
14 127.4 (CH) 6.05,cm 22.4 (CH) 1.03,m 16.7 (CH3) 1.78, s 16.6 (CH3) 1.75, d, 1.2
15 136.3 (CH) 5.15, dd, 9.4, 14.9 14.8 (CH2) 0.41, ddd, 4.7, 5.6, 8.2 113.1 (CH) 5.82, br s 112.6 (CH) 5.81, q, 1.5, 2.7
0.48, ddd, 4.5, 4.5, 8.2
16 22.8 (CH) 1.07,m 14.8 (CH) 0.70,m
17 15.7 (CH2) 0.49, ddd, 4.7, 5.3, 8.2 18.5 (CH3) 1.05, d, 6.2
0.55, ddd, 4.7, 4.7, 8.4
18 15.7 (CH) 0.76,m
19 18.5 (CH3) 1.05, d, 6.0
aMeasured at 100 MHz. bMeasured at 400 MHz. cObscured due to overlapping 1H signals
Table 2. Biological Assay Data for Coibacins AD (14) in
anti-Leishmanial, Cytotoxicity, and Nitric Oxide Assays (IC50
Values in μM)
Leishmania donovani
axenic amastigotes
cytotoxicity
(NCI-H460 cells) nitric oxide
coibacin A (1) 2.4 31.5 20
coibacin B (2) 7.2 17.0 5
coibacin C (3) 18.7 21.3 11
coibacin D (4) 7.8 11.4 21
(9) Green, L. C.; Wagner, D. A.; Glogowski, J.; Skipper, P. L.;
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studies. Coibacin A (1, at 10 μg/mL) was found to sig-
nificantly reduce gene transcription of all four cytokines
tested, with especially notable effects on IL-1β and iNOS
(Figure 2).UsingELISA, changes in protein expression for
some of these inflammatory cytokines were measured in
murine RAW264.7 cells stimulated with lipopolysacchar-
ide (LPS) in the absence or presence of the coibacins.
CoibacinA (1, at 10 μg/mL) was found to significantly reduce
TNF-R and IL-6 secretion (Figure S38 and S40, Supporting
Information). Coibacins BD (24) also affected protein
expression of TNF-R and IL-6 albeit with slightly less potency
(Figures S39 and S41, Supporting Information).
The isolation of both cyclopropyl ring and methyl vinyl
chloride moieties from the same organism suggests intri-
guing biosynthetic possibilities when compared to the
metabolic pathways of curacin A (5) and jamaicamide
A (6). The latter two pathways, originally located in
two different source organisms, were found to have
high sequence identity for the first three enzymatic steps
involved in beta branch formation [HMG Co-A synthase
(HCS), halogenase (HAL), and dehydratase (ECH1)], and
these steps are partially responsible for formation of the
two different functional groups.6 There is considerably less
sequence identity for the decarboxylase (ECH2) and the
enoyl reductase (ER) enzymes. The isolation of co-occur-
ring metabolites containing these two unique structural
moieties from a single organism may indicate variability
in the site of proton delivery (R vs γ) following ECH2-
catalyzed decarboxylation (Figure S42, Supporting
Information). Subsequently, in the latter case of γ-proton
delivery, ER-catalyzed hydride delivery to the β-carbon
leads to cyclopropyl ring formation; no further reaction
occurs in the former case of R-proton addition. Another
structural feature distinguishing the coibacin A/B series
from the C/D series is chain length following the β-branch
manifold; thus, it is possible that the variable presence of
either the cyclopropyl ring or vinyl chloride moieties
determines subsequent PKS extension steps.
It should be noted that the cyclopropyl ring of the
coibacins A and B are of trans stereochemistry, which
contrasts with the cis cyclopropyl ring of curacin A. Thus,
there must be additional, as yet unstudied, points of
divergence between these two biosynthetic pathways.
In summary, we report here the isolation and structure
elucidation of coibacins AD (14), polyketide meta-
bolites possessing novel structures with provocative bio-
synthetic motifs. These cyanobacterial metabolites possess
significant antileishmanial and anti-inflammatory activities
and, thus, may be useful lead structures for drug develop-
ment. Additionally, their co-occurrence gives insight into
how Nature has developed alternative processing to pro-
duce cyclopropyl rings versus vinyl chloride moieties.
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Figure 2. Transcription of pro-inflammatory genes after treat-
ment with coibacin A (1) at 10 μg/mL (bars represent the
mean ( standard deviation; N= 3. *P value < 0.05 compared
to LPS treatment alone. **P value < 0.01 compared to LPS
treatment alone).
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